MRI directed multidisciplinary team preoperative treatment strategy: The way to eliminate positive circumferential margins?

British Journal of Cancer

Volumn 94, Issue 3, 2006, Pages 351-357

  Burton, S ^a   Brown, G ^a   Daniels, I R ^a   Norman, A R ^a   Mason, B ^a   Cunningham, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Chemoradiotherapy; Circumferential resection margin; Magnetic resonance imaging; Multidisciplinary team; Rectal cancer

Indexed keywords

ADJUVANT THERAPY; ARTICLE; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; POLICY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTUM CANCER; TEAMWORK; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 32544450679     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602947     Document Type: Article

References (29)

1. Association of Coloproctology of Great Britain and Ireland (2001) Guidelines for the Management of Colorectal Cancer. ACPGBI: London
2. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, Dixon MF, Quirke P (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344: 707-711
3. Anwar RM, Britton A, Stevens W (2001) Curative resection for rectal carcinoma: definition influences outcome in terms of local recurrence. Colorectal Dis 3: 312-317
4. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, von Meyenfeldt MF, Baeten CG, van Engelshoven JM (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357: 497-504
5. Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, Abbott CR, Scott N, Finan PJ, Johnston D, Quirke P (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235: 449-457
6. Botterill ID, Blunt DM, Quirke P, Sebag-Montefiore D, Sagar PM, Finan PJ, Chalmers AG (2001) Evaluation of the role of pre-operative magnetic resonance imaging in the management of rectal cancer. Colorectal Dis 3: 295-303
7. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT (2003) Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90: 355-364
8. Brown G, Richards CJ, Newcombe RG, Dallimore NS, Radcliffe AG, Carey DP, Bourne MW, Williams GT (1999) Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 211: 215-222
9. Cecil TD, Sexton R, Moran BJ, Heald RJ (2004) Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 47: 1145-1149; discussion 1149-1150
10. Chau I, Allen M, Cunningham D, Tait D, Brown G, Hill M, Sumpter K, Rhodes A, Wotherspoon A, Norman AR, Hill A, Massey A, Prior Y (2003) Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer. Br J Cancer 88: 1017-1024
11. Conroy T, Guillemin F, Stines J, Denis B (1994) [Diagnosis and staging of colorectal cancers]. Rev Prat 44: 2706-2713
12. Delaney CP, Lavery IC, Brenner A, Hammel J, Senagore AJ, Noone RB, Fazio VW (2002) Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers. Ann Surg 236: 203-207
13. Department of Health (2004) Topic 2B. Colorectal Multidisciplinary Team in Manual for Cancer Services
14. Hall NR, Finan PJ, al-Jaberi T, Tsang CS, Brown SR, Dixon MF, Quirke P (1998) Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 41: 979-983
15. Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van Houwelingen HC, van de Velde CJ (1999) Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 25: 368-374
16. Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, Allen PK, Lynch PM, Glober G, Wolff R, Rich TA, Skibber J (1999) Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 44: 1027-1038
17. MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341: 457-460
18. Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JH, van de Velde CJ, Leer JW (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55: 1311-1320
19. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, van Krieken JH (2001) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19: 1976-1984
20. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P (2001) The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 16: 298-304
21. Mulcahy HE, Toner M, Patchett SE, Daly L, O'Donoghue DP (1997) Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death. Dis Colon Rectum 40: 326-331
22. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26: 350-357
23. Quirke P, Williams GT (1998) Minimum dataset for colorectal cancer histopathology reports. Royal College of Pathologists (http://www.rcpath.org/ resources/pdf/colorectalcancer.pdf
24. Rodel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R (2003) Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21: 3098-3104
25. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740
26. Sebag-Montefiore D, Glynne-Jones R, Mortensen N, Bedi C, Wilson C, Geh I, McDonald A (2005) Pooled analysis of outcome measures including the histopatological R0 resection rate after pre-operative chemoradiation for locally advanced rectal cancer. In Tripartite 2005 Colorectal Meeting, Finan PJ (ed), Vol. 7, Supplement 1. p 7. Blackwell Publishing: Dublin, Ireland
27. Shepherd NA, Baxter KJ, Love SB (1995) Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 48: 849-855
28. Stocchi L, Nelson H, Sargent DJ, O'Connell MJ, Tepper JE, Krook JE, Beart Jr R (2001) Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 19: 3895-3902
29. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89: 327-334